National Bank of Canada’s VivoSim Labs VIVS Stock Holding History

National Bank of Canada’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1	Closed	-$10	–	2893
2022 Q4	$10	Buy	+1	New	+$20	﹤0.01%	2747

Other funds holding VIVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

National Bank of Canada's VIVS Position: Q1 2023 in Review

National Bank of Canada sold out of VivoSim Labs (VIVS) in Q1 2023, closing a stake of 1 share — an estimated $10 sold.

National Bank of Canada first reported a position in VIVS in Q4 2022 and held it in 1 quarter. The position peaked at $10 in Q4 2022. 35 funds tracked by Wall St. Rank hold VIVS as of Q1 2023.

National Bank of Canada reported no remaining VivoSim Labs position as of Q1 2023 after selling out during the quarter.
National Bank of Canada sold 1 VivoSim Labs share in Q1 2023, an estimated $10.
National Bank of Canada first reported a position in VivoSim Labs in Q4 2022 and held it in 1 quarter.
National Bank of Canada's VivoSim Labs position peaked at $10 in Q4 2022.
35 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2023.

Based on National Bank of Canada's 13F filing for Q1 2023, filed 12 Apr 2023.